The FDA amended the EUAs for the Pfizer-BioNTech and Moderna COVID-19 Vaccines to allow an additional dose in certain immunocompromised individuals, specifically solid organ transplant recipients or those with conditions that are considered to have an equivalent level of immunocompromise.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/37EAPME
No comments:
Post a Comment